Newsroom
Press releases, stories and publications from Moleculent.
STOCKHOLM, Sweden — November 3, 2026 — Moleculent AB, the life sciences technology company pioneering functional profiling, today announced Glimt, an automated platform that detects cell-cell interactions…
STOCKHOLM, Sweden — April 30, 2026 — Moleculent AB, a life sciences technology company pioneering functional profiling to map cell-cell communication at scale in human tissue, today announced the closing of a $20 million financing round…
The human immune system can identify and eliminate billions of pathogens and maintain surveillance against emerging threats. Yet, cancer cells often evade this defense system, growing unchecked…
STOCKHOLM, Sweden – November 6, 2025 – Moleculent AB today announced the launch of its Techstart early access program…
Over the past decade, researchers mapped genomes, identified new cell types, and made remarkable progress in profiling biology at the single-cell level. But the next layer of biological understanding won’t come from studying cells in isolation, it will come from studying what happens between them…
Each year, more than 330,000 people are diagnosed with melanoma worldwide, and the number continues to rise. While mutations in genes like BRAF and NRAS, two of the most common genetic…
What happens when cell-cell communication breaks down? In the body, disrupted communication between cells can undermine the systems that maintain health and balance. For cancer…
Cell-cell communication is at the heart of biology, driving everything from development to disease progression…
STOCKHOLM, Sweden – June 11, 2024 – Moleculent AB today announced the closing of its oversubscribed Series A financing. The round was led by ARCH Venture Partners…